Related Experiment Video
Updated: Jul 29, 2026

09:02
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Treatment of hepatic metastases from colorectal origin
D F Devereux1, M J Nissenblatt, J Nosher
1Department of Medical Oncology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019.
Abstract:
Currently, chemotherapy for hepatic metastatic disease is palliative at best. However, successful resection of hepatic metastatic deposits from colorectal origin demonstrates a five-year survival, approaching 60 percent in selected cases.

